MicroRNA 3655 (MIR3655)

MicroRNA 3655 (MIR3655) is a member of the microRNA (miRNA) family, a class of short, non-coding RNAs involved in the post-transcriptional regulation of gene expression[3][4]. miRNAs typically function by binding to complementary sequences in target messenger RNAs (mRNAs), leading to translational repression or mRNA degradation[3][4][6]. However, a detailed biological role, disease association, and interacting drugs specific to MIR3655 are currently unknown in the literature. Unlike more well-studied miRNAs, such as miR-155 or miR-140, MIR3655 does not appear in databases of therapeutically targeted miRNAs or in studies linking it to specific cellular functions, disease mechanisms, or drug interactions[1][2]. There is also no evidence currently supporting its use as a biomarker or its relevance to safety concerns. Important Notes: - This target appears to be a misspelled, misidentified, or extremely rare/poorly described microRNA with no validated role as a therapeutic target or notable function in peer-reviewed human biology[1][2]. - No canonical gene, receptor, or protein action has been reported for MIR3655. - The absence of literature support for therapeutic, biomarker, mechanistic, or safety aspects makes MIR3655 unlikely to be a correct or actionable molecular target at this time. If you intended a different microRNA or a more widely recognized target, please check for alternative names or review the spelling and context.

Other names

hsa-mir-3655MIR3655